Against the wave of digital transformation and high-quality development in the life and health industry, Beijing Sino Biological Inc. has entered into in-depth strategic cooperation with Shanghai Hippocrates Health Technology Co., Ltd. to jointly launch the DMS & TMS digital construction project.

The project kick-off meeting was successfully held in an online-offline hybrid format. It marks a crucial step for Sino Biological in digital document management and standardized staff training. By building a full-process digital management system, the company will consolidate compliance foundations for global business layout and drive intelligent, refined development of its biological reagent business.

I. Project Background

As a leading domestic biological reagent enterprise, Sino Biological specializes in R&D, production and sales of recombinant proteins, antibodies and genes, as well as one-stop CRO services. Its products cover over 90 countries and regions, serving more than 8,000 global research institutions and pharmaceutical enterprises. It owns a world-leading human cell expressed recombinant protein library and is a National High-tech Enterprise.

With business expansion and global layout advancement, rising industrial compliance requirements have made traditional document and training management modes inadequate. Common pain points include disordered filing, inconvenient retrieval, version chaos, non-standard training systems and poor compliance traceability. The launch of DMS/TMS is a key strategic move for Sino Biological’s digital transformation. The system will cover global business scenarios, standardize full-lifecycle document management and realize intelligent training management, empowering compliance operation and higher operational efficiency.

II. Project Kick-off Meeting

The kick-off ceremony was co-hosted by both parties, with core project teams attending. Participants clarified the implementation schedule, confirmed key project milestones and established a long-term collaboration mechanism.

Hippocrates released service commitments on optimal resource input, professional delivery and full quality assurance. Executives from both sides delivered speeches, clarifying project significance and implementation requirements, and jointly announced the official project launch. Follow-up special workshops were held to align work plans and tackle key implementation challenges.

III. Leadership Remarks

Sino Biological Representative

Adhering to high-quality development and compliant operation, Sino Biological is committed to providing premium biological reagents and services for global life science research. Global business expansion has sharply increased document volume and raised higher requirements for standardized, compliant staff training.

As a pioneer in life health digital solutions, Hippocrates boasts rich experience in pharmaceutical and biological reagent DMS/TMS construction and compliant digital upgrading. The cooperation will realize standardized document management and intelligent training management, smooth out global digital management links, embed compliance into daily operations, and deepen strategic partnership for further digital upgrading.

Chen Zhonghua, Project Director of Hippocrates

We sincerely appreciate Sino Biological’s trust. This project represents Hippocrates’ in-depth layout in digital compliance for the biological reagent sector. We have assembled a professional team of GMP experts, digital consultants and technical engineers, following the principle of Compliance First, Adaptability Priority, Efficient Delivery.

We will strictly follow project milestones, address core difficulties in document archiving, version control, permission management, as well as training arrangement, hour traceability and performance assessment. The system will seamlessly connect with existing business workflows to achieve refined document control, smart training management and standardized compliance traceability. We will maintain regular communication to ensure high-quality project delivery.

Dr. Tan Ping, General Manager of Hippocrates Business Unit

We thank Sino Biological for its trust and congratulate the official project launch. Sino Biological’s global layout and compliance philosophy align closely with Hippocrates’ mission of Creating Health Value with Technology.

With years of experience in life health digital services, Hippocrates has served over 300 industry clients including Fortune 500 and top pharmaceutical enterprises. We will deploy top-tier resources and strictly comply with GMP, FDA and CSV requirements to deliver customized DMS/TMS solutions.

We believe the project will break digital barriers in document and training management, lift operational efficiency and compliance level, and set a benchmark for industry digital integration. Hippocrates will continue deepening strategic cooperation to support Sino Biological’s global high-quality development.

Core Solution: DMS & TMS Digital System

Developed by Hippocrates’ senior GMP and digital experts, the system fully complies with GMP, FDA and CSV standards, adapting to Sino Biological’s global layout and high compliance demands.

• DMS: Supports full-lifecycle management of R&D, production and sales documents, covering creation, review, archiving, retrieval, version control and permission management. It solves traditional management pain points and meets industrial audit traceability requirements.
• TMS: Covers corporate-wide compliance and professional training, enabling course management, online learning, hour statistics, assessment and certificate control. It improves training efficiency and standardizes staff competency management.
• The system supports global synchronous operation and unified data aggregation, laying a solid digital foundation for Sino Biological’s global integrated management.Company Profile

About Sino Biological

Beijing Sino Biological Inc. is a leading biological reagent enterprise engaged in recombinant protein, antibody and gene reagent business, plus one-stop CRO services. With global market coverage and a leading reagent library, it serves worldwide scientific research and pharmaceutical development as a national high-tech enterprise.

About Hippocrates

Named after Hippocrates, the father of ancient Greek medicine, Hippocrates has over 20 years of industry experience. The company started with GMP compliance consulting and has grown into a leading provider of pharmaceutical digital solutions in China. We have participated in the drafting of national GxP digital standards and possess strong capabilities in both consulting and independent R&D. Our products comply with GxP standards and meet the regulatory requirements of global authorities such as the NMPA, FDA, EMA, and WHO. Our self-developed QMS, DMS, and TMS suites rank among the top tier in China. We also offer VDR, eSIGN, PVS, EBR, WMS, CGT, and eMAH solutions, along with one-stop services covering compliance control, data governance, and CSV validation, supporting both group-level and global deployment. Our clients include leading domestic pharmaceutical companies, benchmark biotech enterprises, and multinational pharmaceutical companies. To date, we have helped hundreds of companies achieve zero-defect audits, empowering pharmaceutical enterprises in digital transformation, cost reduction, efficiency improvement, and global growth.